DELAWARE
|
36-4324765
|
(State
of Incorporation)
|
(I.R.S.
Employer Identification No.)
|
870
NORTH COMMONS DRIVE
|
60504
|
AURORA,
ILLINOIS
|
(Zip
Code)
|
(Address
of principal executive offices)
|
YES
|
X
|
NO
|
Large
accelerated filer
|
X
|
Accelerated
filer
|
Non-accelerated
filer
|
YES
|
NO
|
X
|
Part
I. Financial Information
|
Page
|
|
Item
1.
|
Financial
Statements
|
|
Three
and Six Months Ended March 31, 2007 and 2006
|
3
|
|
March
31, 2007, and September 30, 2006
|
4
|
|
Six
Months Ended March 31, 2007 and 2006
|
5
|
|
6
|
||
Item
2.
|
12 | |
Item
3.
|
18
|
|
Item
4.
|
19
|
|
Part
II. Other Information
|
||
Item
1.
|
19
|
|
Item
1A.
|
20
|
|
Item
2.
|
23
|
|
Item
4.
|
24
|
|
Item
6.
|
24
|
|
25
|
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||
|
March
31,
|
March
31,
|
|||||||||||
2007
|
|
|
2006
|
2007
|
|
|
2006
|
||||||
Revenue
|
$
|
76,987
|
$
|
67,389
|
$
|
158,803
|
$
|
148,877
|
|||||
Cost
of goods sold
|
43,188
|
35,855
|
85,689
|
78,906
|
|||||||||
Gross
profit
|
33,799
|
31,534
|
73,114
|
69,971
|
|||||||||
Operating
expenses:
|
|||||||||||||
Research,
development and technical
|
13,481
|
11,321
|
25,728
|
22,980
|
|||||||||
Selling
and marketing
|
5,847
|
5,075
|
11,323
|
10,101
|
|||||||||
General
and administrative
|
9,537
|
8,244
|
18,962
|
16,658
|
|||||||||
Total
operating expenses
|
28,865
|
24,640
|
56,013
|
49,739
|
|||||||||
Operating
income
|
4,934
|
6,894
|
17,101
|
20,232
|
|||||||||
Other
income, net
|
1,260
|
1,090
|
2,434
|
1,806
|
|||||||||
Income
before income taxes
|
6,194
|
7,984
|
19,535
|
22,038
|
|||||||||
Provision
for income taxes
|
1,703
|
2,547
|
5,919
|
7,030
|
|||||||||
Net
income
|
$
|
4,491
|
$
|
5,437
|
$
|
13,616
|
$
|
15,008
|
|||||
Basic
earnings per share
|
$
|
0.19
|
$
|
0.22
|
$
|
0.57
|
$
|
0.62
|
|||||
Weighted
average basic shares outstanding
|
23,708
|
24,233
|
23,774
|
24,299
|
|||||||||
Diluted
earnings per share
|
$
|
0.19
|
$
|
0.22
|
$
|
0.57
|
$
|
0.62
|
|||||
Weighted
average diluted shares outstanding
|
23,718
|
24,233
|
23,777
|
24,299
|
March
31,
2007
|
September
30,
2006
|
||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
57,818
|
$
|
54,965
|
|||
Short-term
investments
|
105,750
|
110,965
|
|||||
Accounts
receivable, less allowance for doubtful accounts of $530
at
|
|||||||
March
31, 2007, and $551 at September 30, 2006
|
47,563
|
48,028
|
|||||
Inventories
|
42,102
|
40,326
|
|||||
Prepaid
expenses and other current assets
|
9,315
|
4,785
|
|||||
Deferred
income taxes
|
2,540
|
2,436
|
|||||
Total
current assets
|
265,088
|
261,505
|
|||||
Property,
plant and equipment, net
|
123,839
|
130,176
|
|||||
Goodwill
|
4,569
|
4,565
|
|||||
Other
intangible assets, net
|
13,082
|
11,447
|
|||||
Deferred
income taxes
|
4,166
|
1,365
|
|||||
Other
long-term assets
|
2,756
|
3,075
|
|||||
Total
assets
|
$
|
413,500
|
$
|
412,133
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
9,330
|
$
|
15,104
|
|||
Capital
lease obligations
|
1,297
|
1,254
|
|||||
Accrued
expenses, income taxes payable and other current
liabilities
|
18,710
|
22,475
|
|||||
Total
current liabilities
|
29,337
|
38,833
|
|||||
Capital
lease obligations
|
3,885
|
4,420
|
|||||
Other
long-term liabilities
|
1,263
|
1,109
|
|||||
Total
liabilities
|
34,485
|
44,362
|
|||||
Commitments
and contingencies (Note 5)
|
|||||||
Stockholders’
equity:
|
|||||||
Common
stock:
|
|||||||
Authorized:
200,000,000 shares, $0.001 par value
|
|||||||
Issued:
25,418,250 shares at March 31, 2007, and
|
|||||||
25,254,719
shares at September 30, 2006
|
24
|
24
|
|||||
Capital
in excess of par value of common stock
|
164,708
|
157,463
|
|||||
Retained
earnings
|
264,623
|
251,007
|
|||||
Accumulated
other comprehensive income
|
651
|
272
|
|||||
Treasury
stock at cost, 1,627,337 shares at March 31, 2007,
|
|||||||
and
1,297,167 shares at September 30, 2006
|
(50,991
|
)
|
(40,995
|
)
|
|||
Total
stockholders’ equity
|
379,015
|
367,771
|
|||||
Total
liabilities and stockholders’ equity
|
$
|
413,500
|
$
|
412,133
|
|
Six
Months Ended
March
31,
|
||||||
2007
|
2006
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
income
|
$
|
13,616
|
$
|
15,008
|
|||
Adjustments
to reconcile net income to net cash provided
by operating activities:
|
|||||||
Depreciation
and amortization
|
12,229
|
9,800
|
|||||
Loss
on equity investment
|
-
|
566
|
|||||
Share-based
compensation expense
|
6,257
|
5,145
|
|||||
Deferred
income tax benefit
|
(2,903
|
)
|
(2,902
|
)
|
|||
Non-cash
foreign exchange (gain) loss
|
(127
|
)
|
889
|
||||
Other
|
655
|
297
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
648
|
2,046
|
|||||
Inventories
|
(1,660
|
)
|
(4,526
|
)
|
|||
Prepaid
expenses and other assets
|
(4,201
|
)
|
3,227
|
||||
Accounts
payable
|
(5,253
|
)
|
1,341
|
||||
Accrued
expenses, income taxes payable and other liabilities
|
(3,823
|
)
|
(2,684
|
)
|
|||
Net
cash provided by operating activities
|
15,438
|
28,207
|
|||||
Cash
flows from investing activities:
|
|||||||
Additions
to property, plant and equipment
|
(5,605
|
)
|
(15,460
|
)
|
|||
Proceeds
from the sale of property, plant and equipment
|
172
|
17
|
|||||
Acquisition
of business
|
-
|
(2,282
|
)
|
||||
Acquisition
of patent license
|
(3,000
|
)
|
-
|
||||
Purchases
of short-term investments
|
(62,375
|
)
|
(81,655
|
)
|
|||
Proceeds
from the sale of short-term investments
|
67,590
|
82,242
|
|||||
Net
cash used in investing activities
|
(3,218
|
)
|
(17,138
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Repurchases
of common stock
|
(9,995
|
)
|
(7,995
|
)
|
|||
Net
proceeds from issuance of stock
|
988
|
789
|
|||||
Principal
payments under capital lease obligations
|
(491
|
)
|
(460
|
)
|
|||
Net
cash used in financing activities
|
(9,498
|
)
|
(7,666
|
)
|
|||
Effect
of exchange rate changes on cash
|
131
|
(242
|
)
|
||||
Increase
in cash
|
2,853
|
3,161
|
|||||
Cash
and cash equivalents at beginning of period
|
54,965
|
44,436
|
|||||
Cash
and cash equivalents at end of period
|
$
|
57,818
|
$
|
47,597
|
Supplemental
disclosure of noncash investing and financing activities:
|
|||||||
Purchases
of property, plant and equipment in accrued liabilities and accounts
payable at the end of the period
|
$
|
502
|
$
|
1,498
|
|||
Issuance
of restricted stock
|
4,487
|
68
|
March
31,
|
September
30,
|
||||||
2007
|
2006
|
||||||
Raw
materials
|
$
|
21,658
|
$
|
18,623
|
|||
Work
in process
|
1,537
|
1,805
|
|||||
Finished
goods
|
18,907
|
19,898
|
|||||
Total
|
$
|
42,102
|
$
|
40,326
|
March
31, 2007
|
September
30, 2006
|
||||||||||||||||
|
Gross
Carrying
|
Accumulated
|
Gross
Carrying
|
|
Accumulated
|
||||||||||||
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
Amortization
|
|||||||
Other
intangible assets subject to amortization:
|
|||||||||||||||||
Product
technology
|
$
|
5,380
|
$
|
404
|
$
|
5,380
|
$ |
135
|
|||||||||
Acquired
patents and licenses *
|
8,000
|
1,482
|
5,000
|
479
|
|||||||||||||
Trade
secrets and know-how
|
2,550
|
2,550
|
2,550
|
2,550
|
|||||||||||||
Distribution
rights, customer lists and other
|
1,457
|
1,152
|
1,457 |
1,059
|
|||||||||||||
Total
other intangible assets subject to amortization
|
17,387
|
5,588
|
14,387
|
4,223
|
|||||||||||||
Total
other intangible assets not subject to amortization
**
|
1,283
|
1,283 | |||||||||||||||
Total
other intangible assets
|
$
|
18,670
|
$
|
5,588
|
$
|
15,670
|
$ |
4,223
|
Fiscal
Year
|
Estimated
amortization
expense
|
||
Remainder
of 2007
|
$1,440
|
||
2008
|
2,838
|
||
2009
|
1,663
|
||
2010
|
854
|
||
2011
|
847
|
||
2012
|
847
|
March
31,
|
September
30,
|
||||||
2007
|
2006
|
||||||
Accrued
compensation
|
$
|
8,751
|
$
|
12,948
|
|||
Goods
and services received, not yet invoiced
|
4,342
|
3,088
|
|||||
Warranty
accrual
|
435
|
924
|
|||||
Income
taxes payable
|
-
|
764
|
|||||
Taxes,
other than income taxes
|
1,938
|
2,270
|
|||||
Other
|
3,244
|
2,481
|
|||||
Total
|
$
|
18,710
|
$
|
22,475
|
Balance
as of September 30, 2006
|
$
924
|
Additions
charged to expense
|
-
|
Deductions
|
(489)
|
Balance
as of March 31, 2007
|
$
435
|
Three
Months Ended
|
Six
Months Ended
|
||||||||||||
March
31,
|
March
31,
|
||||||||||||
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
||||
Cost
of goods sold
|
$
|
196
|
$
|
163
|
$
|
383
|
$
|
313
|
|||||
Research,
development and technical
|
281
|
243
|
571
|
476
|
|||||||||
Selling
and marketing
|
321
|
259
|
630
|
504
|
|||||||||
General
and administrative
|
2,534
|
1,986
|
4,673
|
3,852
|
|||||||||
Total
share-based compensation expense
|
3,332
|
2,651
|
6,257
|
5,145
|
|||||||||
Tax
benefit
|
1,190
|
981
|
2,235
|
1,903
|
|||||||||
Total
share-based compensation expense, net of tax
|
$
|
2,142
|
$
|
1,670
|
$
|
4,022
|
$
|
3,242
|
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||
|
|
March
31,
|
March
31,
|
||||||||||
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
||||
Interest
income
|
$
|
1,337
|
$
|
1,333
|
$
|
2,790
|
$
|
2,544
|
|||||
Interest
expense
|
(132
|
)
|
(135
|
)
|
(256
|
)
|
(272
|
)
|
|||||
Other
income (expense)
|
55
|
(108
|
)
|
(100
|
)
|
(466
|
)
|
||||||
Total
other income, net
|
$
|
1,260
|
$
|
1,090
|
$
|
2,434
|
$
|
1,806
|
|
Three
Months Ended
|
Six
Months Ended
|
|||||||||||
|
|
March
31,
|
March
31,
|
||||||||||
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
||||
Net
income
|
$
|
4,491
|
$
|
5,437
|
$
|
13,616
|
$
|
15,008
|
|||||
Other
comprehensive income:
|
|||||||||||||
Net
unrealized gain on derivative
|
|||||||||||||
instruments
|
9
|
9
|
18
|
18
|
|||||||||
Foreign
currency translation adjustment
|
612
|
480
|
361
|
(1,415
|
)
|
||||||||
Total
comprehensive income
|
$
|
5,112
|
$
|
5,926
|
$
|
13,995
|
$
|
13,611
|
Three
Months Ended
|
Six
Months Ended
|
||||||||||||
|
|
March
31,
|
March
31,
|
||||||||||
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
||||
Numerator:
|
|||||||||||||
Earnings
available to common shares
|
$
|
4,491
|
$
|
5,437
|
$
|
13,616
|
$
|
15,008
|
|||||
Denominator:
|
|||||||||||||
Weighted
average common shares
|
23,708,131
|
24,232,779
|
23,774,262
|
24,299,165
|
|||||||||
(Denominator
for basic calculation)
|
|||||||||||||
Weighted
average effect of dilutive securities:
|
|||||||||||||
Share-based
compensation
|
10,099
|
268
|
2,834
|
50
|
|||||||||
Diluted
weighted average common shares
|
23,718,230
|
24,233,047
|
23,777,096
|
24,299,215
|
|||||||||
(Denominator
for diluted calculation)
|
|||||||||||||
Earnings
per share:
|
|||||||||||||
Basic
|
$
|
0.19
|
$
|
0.22
|
$
|
0.57
|
$
|
0.62
|
|||||
Diluted
|
$
|
0.19
|
$
|
0.22
|
$
|
0.57
|
$
|
0.62
|
· |
Research
related to fundamental CMP technology;
|
· |
Development
and formulation of new and enhanced CMP slurry and pad products;
|
· |
Process
development to support rapid and effective commercialization of new
products;
|
· |
Evaluation
of new polishing applications related to our ESF initiative;
and
|
· |
Applications
support.
|
CONTRACTUAL
OBLIGATIONS
|
|
|
|
Less
Than
|
|
|
1-3
|
|
|
3-5
|
|
|
After
5
|
|
||
(In
millions)
|
|
|
Total
|
|
|
1
Year
|
|
|
Years
|
|
|
Years
|
|
|
Years
|
|
Capital
lease obligations
|
$
|
5.2
|
$
|
1.3
|
$
|
2.3
|
$
|
1.6
|
$
|
-
|
||||||
Operating
leases
|
2.4
|
1.5
|
0.9
|
-
|
-
|
|||||||||||
Purchase
obligations
|
35.8
|
27.7
|
5.9
|
2.2
|
-
|
|||||||||||
Other
long-term liabilities
|
1.3
|
-
|
-
|
-
|
1.3
|
|||||||||||
Total
contractual obligations
|
$
|
44.7
|
$
|
30.5
|
$
|
9.1
|
$
|
3.8
|
$
|
1.3
|
Period
|
Total
Number of Shares Purchased
|
|
|
Average
Price Paid Per Share
|
|
|
Total
Number of Shares Purchased as Part of Publicly Announced Plans or
Programs
|
|
|
Approximate
Dollar Value of Shares that May Yet Be Purchased Under the Plans
or
Programs (in thousands)
|
|
||
Jan.
1 through
Jan.
31, 2007
|
29,530
|
$ |
30.10
|
29,530
|
$
|
17,119
|
|||||||
Feb.
1 through
Feb.
28, 2007
|
100,166
|
|
31.06
|
100,166
|
$
|
14,009
|
|||||||
Mar.
1 through
Mar.
31, 2007
|
-
|
-
|
-
|
$
|
14,009
|
||||||||
Total
|
129,696
|
$
|
30.84
|
129,696
|
$
|
14,009
|
Number
of Votes For Election
|
Number
of Votes Withheld
|
|
H.
Laurance Fuller
|
22,412,947
|
86,098
|
Edward
J. Mooney
|
22,410,755
|
88,290
|
The
exhibit numbers in the following list correspond to the number assigned
to
such exhibits in the Exhibit Table of Item 601 of Regulation
S-K:
|
Exhibit
Number
|
Description
|
|
3.2
|
Amended
and Restated By-Laws of Cabot Microelectronics Corporation, as amended
and
restated March 6, 2007.
|
|
10.6 |
Form
of Cabot Microelectronics Corporation Second Amended and Restated
2000
Equity Incentive Plan Restricted Stock Award
Agreement (directors).*
|
|
31.1
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a)
of the
Securities Exchange Act of 1934, as adopted pursuant to Section 302
of the
Sarbanes-Oxley Act of 2002.
|
|
31.2
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a)
of the
Securities Exchange Act of 1934, as adopted pursuant to Section 302
of the
Sarbanes-Oxley Act of 2002.
|
|
32.1
|
Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002.
|
CABOT
MICROELECTRONICS CORPORATION
|
|
Date:
May 9, 2007
|
/s/
WILLIAM S. JOHNSON
|
William
S. Johnson
|
|
Vice
President and Chief Financial Officer
|
|
[Principal
Financial Officer]
|
|
Date:
May 9, 2007
|
/s/
THOMAS S. ROMAN
|
Thomas
S. Roman
|
|
Corporate
Controller
|
|
[Principal
Accounting Officer]
|